Literature DB >> 2897256

Colorimetric assay of blood coagulation factor XIII in plasma.

K N Lee1, P J Birckbichler, M K Patterson.   

Abstract

In this new colorimetric assay for Factor XIII in plasma, 5-(biotinamido)pentylamine is used as the amine substrate. Factor XIII, a zymogen, is transformed by thrombin and Ca2+ to active Factor XIIIa, and the incorporation of 5-(biotinamido)pentylamine into N,N-dimethylcasein is used to measure catalytically active Factor XIIIa. The biotinylated enzymatic product is immobilized onto 96-well microtiter plates, complexed with streptavidin-beta-galactosidase, and the absorbance at 405 nm is monitored for production of p-nitrophenol from p-nitrophenyl-beta-D-galactopyranoside. Concentrations of N,N-dimethylcasein, 5-(biotinamido)pentylamine, Ca2+, and thrombin were chosen to allow near-maximum velocity of amine incorporation. A linear relationship was obtained between assay product and plasma volume, from 0.5 to 50 microL of plasma. Results correlated well (r greater than 0.924) with those from the most frequently utilized radiometric filter-paper assay for Factor XIII. The method appears to be ideal for routine diagnostic estimation of Factor XIII in plasma because of its simplicity, its lack of use of radioisotopes, and its potential for assay of large numbers of samples by use of microtiter plates and automated plate readers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897256

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

2.  Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains.

Authors:  Mohammad Suhail Akhter; Sneha Singh; Hamideh Yadegari; Vytautas Ivaskevicius; Johannes Oldenburg; Arijit Biswas
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

3.  New developments in the management of congenital Factor XIII deficiency.

Authors:  Zehra Fadoo; Quratulain Merchant; Karim Abdur Rehman
Journal:  J Blood Med       Date:  2013-05-28

4.  Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps.

Authors:  Krisztián Csomós; Endre Kristóf; Bernadett Jakob; István Csomós; György Kovács; Omri Rotem; Judit Hodrea; Zsuzsa Bagoly; Laszlo Muszbek; Zoltán Balajthy; Éva Csősz; László Fésüs
Journal:  Cell Death Dis       Date:  2016-08-11       Impact factor: 8.469

5.  Structure functional insights into calcium binding during the activation of coagulation factor XIII A.

Authors:  Sneha Singh; Johannes Dodt; Peter Volkers; Emma Hethershaw; Helen Philippou; Vytautus Ivaskevicius; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.